GlassScriptPhysician profile
Srinivas R Puli
NPI 1326069824
$8,747.30
in general payments reported to CMS, 2019-2025
21 companies · $1,482 in 2025
The $1,482 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $90.48 · 2021: $280 · 2022: $991 · 2023: $4,375 · 2024: $1,267 · 2025: $1,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,983 · Travel and Lodging: $3,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,982.69 |
| Travel and Lodging | $3,141.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $2,072.61 | 2023 | Single Use Electrosurgical Knife Kd-655, Single Use Electrosurgical Hemostatic Forceps, Disposable Distal Attachment |
| Boston Scientific Corporation | $1,969.42 | 2019-2025 | Exalt Model D, General - Biliary Devices, Biliary Stent Introducer |
| Ovesco Endoscopy USA, INC. | $1,138.86 | 2023 | |
| Conmed Corporation | $1,060.68 | 2022-2025 | Conmed Biliary, Conmed Generators, Conmed Hemostasis |
| Abbvie INC. | $632.54 | 2020-2024 | |
| Omega Medical Imaging, LLC | $392.26 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $228.41 | 2022-2023 | Zeposia |
| Genzyme Corporation | $222.13 | 2022-2025 | |
| Janssen Biotech, INC. | $181.75 | 2024-2025 | Tremfya, Stelara |
| Pentax of America, INC. | $149.78 | 2025 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Ipsen Biopharmaceuticals, INC | $110.77 | 2025 | Iqirvo |
| Merit Medical Systems INC | $104.10 | 2024 | Alimaxx-Esophageal Stent/Delivery System, Esophyx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.84 | 2021-2022 | |
| Lilly USA, LLC | $97.09 | 2024 | Omvoh |
| Endogastric Solutions, INC | $72.53 | 2023 | Esophyx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Creo Medical INC. | $61.98 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.42 | 2025 | Entyvio |
| Cook Medical LLC | $41.58 | 2021 | |
| Olympus America INC. | $24.98 | 2021 | |
| Erbe USA INC | $21.48 | 2021 | |
| Ethicon US, LLC | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinivas Puli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.